MYL) by 14.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned …
BNS1h
Looking at Mylan NV (NASDAQ:MYL)’s fundamentals some investors …
Wall Street
To thwart Mylan, Mr. Papa promised an earnings and growth surge that never materialized, souring investors on the stock. The market today …
Perrigo
Sanofi SA (ADR) (NYSE:SNY) sued Mylan, accusing the pharmaceutical company of engaging ... and …
Sanofi
The stock has actually made sharp losses in the past year ... GSK warns of impact from generic drugs after solid Q1 Food and Drug …
General Electric
Sanofi contends in its suit that Mylan executives required schools that stock emergency allergy treatments to vow not to use lower-cost EpiPen competitors. Those school sales prompted the New York Attorney General’s …
Michael Bloomberg
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are compelling buys, or offer up …
NASDAQ1mon
NASDAQ
Mylan (NASDAQ: MYL), the company behind severe allergic reaction ... 10 stocks we like better than Valeant Pharmaceuticals When investing …